Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
FQuintero (talk | contribs)
editor
355 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(64 intermediate revisions by 5 users not shown)
Line 54: Line 54:
|
|
|
|
|PENDING/complete?
|complete
|
|
|FQR
|FQR
|
|8/4/2020 before submission
|
|
|-
|-
Line 71: Line 71:
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Mark Evans (trainee), Fabiola Quintero-Rivera
|(trainee), Daynna J.Wolff
|
|
|
|
|PENDING
|pending faculty review
|
|
|FQR
|FQR
Line 99: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|9/1/20
|
|PENDING
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
Line 121: Line 121:
|Thuy Phung +Jordan Lowery
|Thuy Phung +Jordan Lowery
|
|
|9/1/20
|
|complete
|complete
|
|
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 352: Line 352:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 366: Line 366:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS
|
|
|-
|-
Line 374: Line 374:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
|02/03/2021||JH / MS
|
|
|
|
Line 382: Line 382:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
| ||JH / MS
|
|03/02/2021-MS
|
|
|-
|-
Line 392: Line 392:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/02/2021-MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 409: Line 409:
|
|
|JH / MS
|JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021-MS (re-review)
|
|
|-
|-
Line 425: Line 425:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 433: Line 433:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 441: Line 441:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 449: Line 449:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|02/24/2021-MS (re-review)
|
|
|-
|-
Line 674: Line 674:
| ||JH / MS
| ||JH / MS
|
|
|Check reference format
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
Line 684: Line 684:
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|
|
|??
|PENDING
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|
|
|??
|PENDING
| ||JH / MS
| ||JH / MS
|
|
Line 757: Line 757:
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 774: Line 774:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 801: Line 801:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 826: Line 826:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Disease
|Helene Bruyere
|Chenkai Ma
|
|
|
|
Line 877: Line 886:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
| ||Snehal Patel (SP)
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
| ||YA
|
|
|SP
|
|
|-
| || ||
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
| ||
|
|
|SP
|
|
|Malini to review
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|Complete
| ||Snehal Patel (SP)
|
|
|SP
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 974: Line 984:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 983: Line 993:
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Renu Bajaj
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|PENDING
|Complete
| ||SP
|
|SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease||
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease||
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Mu Heavy Chain  Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|   Gamma Heavy Chain Disease||Disease||Manisha Sutariya
|
|
|
|
|PENDING
|Complete
|
|5/26/2021||SP
|SP
|
|
|
|
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Primary Amyloidosis||Disease||
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease||
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
Line 1,116: Line 1,131:
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|           Primary Amyloidosis||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|         POEMS Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|         TEMPI Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|
|3/9/21
|
|
|PENDING
|PENDING
Line 1,169: Line 1,180:
|
|
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|
|PENDING
|Complete
|
|5/28/2021||SP
|SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|Complete
|Complete
|8/16/2020
|11/11/2020
|SP
|SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|9/30/20
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|
|8/15/20
|PENDING
|PENDING
|
|
Line 1,212: Line 1,224:
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|8/31/20
|PENDING
|PENDING
|
|
Line 1,221: Line 1,233:
|
|
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|8/15/20
|PENDING
|
|
|Complete
|8/16/2020
|SP
|SP
|
|
|
|
|-
|-
| || ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|
|9/30/20
|
|Complete
| ||
|5/26/2021||SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|PENDING
|PENDING
|
| ||SP
|Greg Corboy (GC)
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|
|
|SP
| ||GC
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
| ||GC
|
|SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
| || ||
|
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
| ||GC
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,295: Line 1,310:
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
Line 1,303: Line 1,318:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
Line 1,311: Line 1,326:
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
|
Line 1,319: Line 1,334:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
Line 1,327: Line 1,342:
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
|
Line 1,335: Line 1,350:
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
Line 1,351: Line 1,366:
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,359: Line 1,374:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,367: Line 1,382:
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,375: Line 1,390:
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
Line 1,391: Line 1,406:
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,399: Line 1,414:
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
Line 1,407: Line 1,422:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
Line 1,415: Line 1,430:
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
Line 1,423: Line 1,438:
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|
|3/11/21
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|
|
|-
|-
| || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
| ||GC
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|PENDING
|
| ||SP
| ||GC
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||
| || ||
|
|
|
|
|
|
| ||SP
| ||
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Linda Cooley, Lisa Lansdon (trainee)
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
Line 1,495: Line 1,510:
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
Line 1,519: Line 1,534:
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
Line 1,527: Line 1,542:
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease||
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
Line 1,636: Line 1,652:
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,660: Line 1,676:
|
|
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
|    Lymphomatoid Papulosis||Disease||
|
|
|
|
Line 1,668: Line 1,684:
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
Line 1,676: Line 1,692:
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
Line 1,684: Line 1,700:
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
Line 1,692: Line 1,708:
|
|
|-
|-
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
Line 1,745: Line 1,757:
|
|
|-
|-
| || ||
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||Associate Editor??
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
| || ||
|
|
|
|
Line 1,793: Line 1,809:
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
 
Fabiola Quintero-Rivera
|
|
|
|PENDING
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||
|GC
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Histiocytosis||Disease||
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Sarcoma||Disease||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|   Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|   Langerhans Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
|
Line 2,083: Line 2,203:
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
| || ||
|BCR
|Brian Davis
|
|
|
|
|Complete
|8/10/18
|
|
| ||
|
|
|
|
|-
|-
| || ||
|ABL1
|Brian Davis
|
|
|
|
|Complete
|4/16/19
|
|
| ||
|
|
|
|
|-
|-
| || ||
|RUNX1
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
| ||
|
|
|
|
|-
|-
| || ||
|RUNX1T1
|Brian Davis
|
|
|
|
|Complete
|5/23/19
|
|
| ||
|
|
|
|
|-
|-
| || ||
|MYH11
|Brian Davis
|
|
|
|
|Complete
|8/6/18
|
|
| ||
|
|
|
|
|-
|-
| || ||
|FLT3
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
|NPM1
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
| ||
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|
|
|Complete
|8/10/18
|
|
|
|
|
|
|-
|-
|ABL1
|CEBPA
|Brian Davis
|Gordana
|
|
|
|
|Complete
|Complete
|4/16/19
|
|
|
|
|
|
|
|-
|-
|RUNX1
|IDH1
|Brian Davis
|Paul De Fazio
|
|
|
|
|Complete
|Complete
|6/9/19
|
|
|
|
|
|
|
|-
|-
|RUNX1T1
|IDH2
|Brian Davis
|Paul De Fazio
|
|
|
|
|Complete
|Complete
|5/23/19
|
|
|
|
|
|
|
|-
|-
|MYH11
|PML
|Brian Davis
|Brian Davis
|
|
|
|
|Complete
|Complete
|8/6/18
|12/5/18
|
|
|
|
|
|
|-
|-
|FLT3
|RARA
|Kay Weng Choy
|Brian Davis
|
|
|
|
|Complete
|Complete
|
|8/3/18
|
|
|
|
|
|
|-
|-
|NPM1
|ETV6
|Kay Weng Choy
|Brian Davis
|
|
|
|
|Complete
|Complete
|
|6/9/19
|
|
|
|
|
|
|-
|-
|TP53
|KIT
|Kay Weng Choy
|Brian Davis
|
|
|
|
|Complete
|Complete
|
|10/1/18
|
|
|
|
|
|
|-
|-
|DNMT3A
|CBFB
|Kay Weng Choy
|Brian Davis
|
|
|
|
|Complete
|Complete
|
|8/2/18
|
|
|
|
|
|
|-
|-
|CEBPA
|GATA2
|Gordana
|Kay Weng Choy
|
|
|
|
Line 2,260: Line 2,396:
|
|
|-
|-
|IDH1
|PTEN
|Paul De Fazio
|Beth Pitel
|
|
|
|
|Complete
|Pending
|
|
|
|
Line 2,270: Line 2,406:
|
|
|-
|-
|IDH2
|MLTT3
|Paul De Fazio
|
|
|
|
|Complete
|
|
|
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|
|
|
|-
|-
|RARA
|MECOM
|Brian Davis
|Brian Davis
|
|
|
|
|Complete
|Pending
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|KIT
|FGFR1(FLT2)
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|
|
Line 2,350: Line 2,436:
|
|
|-
|-
|MLTT3
|KMT2A
|
|
|
|
Line 2,360: Line 2,446:
|
|
|-
|-
|MECOM
|DEK
|Brian Davis
|Wahab A. Khan
|
|
|
|
Line 2,370: Line 2,456:
|
|
|-
|-
|FGFR1(FLT2)
|NUP214
|Brian Davis
|Wahab A. Khan
|
|
|
|
|Pending
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|
|
|
|
|
|
|
|
|-
|NUP214
|
|
|
|
|
|
|
|
Line 2,700: Line 2,756:
|
|
|-
|-
|
|BRCA1
|
|
|
|
Line 2,710: Line 2,766:
|
|
|-
|-
|
|BRCA2
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"